Perspectives

Should I be afraid of getting COVID again?


 

Am I safe from reinfection?

In all honesty, we’re not entirely sure. But it is important to recognize a few points when considering your relative safety.

  • The immune system is far from perfect. Not everyone has a robust immune response. And in those who do, the immune response can wane over time, potentially allowing for reinfection. While rare, there have already been some clearly documented reinfections, four that have been confirmed and published; two patients (in Nevada and Ecuador) actually fared worse the second time around.
  • The virus can mutate and escape detection by the immune system. One could still be susceptible to reinfection from a different strain. (At least, this remains the case with the influenza virus.) There is some evidence that SARS-CoV-2 does not mutate rapidly, and hence this may not be a problem. But we don’t know for certain, at least as of yet.
  • Even a vigorous immune response can be overwhelmed by the virus. It is unclear whether the relative length of time and the amount of virus exposure could undermine a previously primed immune system.

A prior infection and a consequent healthy immunity may help you combat a reinfection but it does not prevent you from harboring or carrying the virus. You may be asymptomatic, but you can still be a carrier and spread the infection. I am a strong advocate for limiting your exposure to others no matter your previous exposure status, in order to limit the spread of the virus.

So, what should I do?

I guess the answer is that you can’t be too careful. Not everyone has had their antibody levels tested, and even if positive, it is unclear how well that affords protection. It is best to presume that you are vulnerable for a reinfection and that you can still carry and spread the virus. This may be the safest approach until we actually achieve herd immunity through vaccination.

Even then, for a period of time, there will remain a sense of uncertainty. So, containment strategies inclusive of distancing and masking will and should remain a way of life at least until mid-2021, when we will be in a better position to reassess the landscape.

The surge is back. As I repay my debt and get back to the front line, I will continue to mask up and practice distancing. I am taking no chances of getting reinfected or being an asymptomatic carrier.

I had COVID, I also have antibodies, and I will be taking the vaccine. I implore you all to do the same.

Jag Singh is a physician, scientist, and professor at Harvard. He is passionate about social issues, leadership, digital health, and medical innovations. You can follow him on Twitter @JagSinghMD.

A version of this article first appeared on Medscape.com.

Pages

Recommended Reading

COVID-19 vaccines: Preparing for patient questions
MDedge Rheumatology
FDA OKs emergency use of Pfizer COVID-19 vaccine
MDedge Rheumatology
CDC panel recommends Pfizer’s COVID-19 vaccine for people 16 and over
MDedge Rheumatology
Baricitinib combo for COVID-19 accelerates recovery, study shows
MDedge Rheumatology
Understanding messenger RNA and other SARS-CoV-2 vaccines
MDedge Rheumatology
COVID-related harm to HCWs must be tracked more rigorously: NAS panel
MDedge Rheumatology
FDA clears first OTC rapid at-home COVID diagnostic test
MDedge Rheumatology
COVID-19 vaccines: Safe for immunocompromised patients?
MDedge Rheumatology
Vaccine rollout on track, expect 300 million doses through March: Feds
MDedge Rheumatology
Moderna COVID-19 vaccine wins decisive recommendation from FDA panel
MDedge Rheumatology